Seeking Alpha

tadoboy

tadoboy
Send Message
View as an RSS Feed
View tadoboy's Comments BY TICKER:
Latest  |  Highest rated
  • PharmaCyte Biotech (Formerly, Nuvilex): Where, Oh Where Did The Cash Flow Go... [View article]
    Hey everyone. No need to worry about PMCB's cash flow. They're printing and selling stock the way Lays sells potato chips -- by the bag full. The only problem is that it appears that most of that money seems to go to admin. And so very little ever makes it to the R&D department. All those pancreatic cancer patients waiting for PMCB's Phase III trial are still waiting and waiting and waiting.
    Mar 27, 2015. 03:49 PM | Likes Like |Link to Comment
  • 48 Marijuana Stocks - A Post-Mortem: Part I [View article]
    Anthony. I love your work -- especially PMCB. But I am a little confused. You say that none of the 48 companies is trading above their 52 week high. If they were -- then that would be their new 52 week high.

    Maybe I'm just not that smart. Can you give me an example of a company that is now trading above its 52 week high? Thanx
    Mar 7, 2015. 01:47 PM | 1 Like Like |Link to Comment
  • PharmaCyte Biotech: A Re-Balanced, Statistical Look At Stock Promotions [View article]
    Well, did they say how many billions this plan to do something in the future is going to generate? Bet it was a lot!
    Feb 11, 2015. 01:52 PM | Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    What are you talking about? The high my dear was $4.93 in Dec. 2014!!! And its been sliding ever since!

    "Many will lose the opportunity to get in at current prices" You sound like a shill?

    Tell us who is this partner? Who told you that there will be new board members. Please cite the source of this new and exciting information.
    Jan 30, 2015. 05:34 PM | Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    Absolutely CTIX did de-risk Brilacidin. That's why the price went from $.70 (when I bought it) to $4.50 (when I sold it.)

    The point is a lot of positives are now baked into the present price. Dilution is coming. I think a better entry point will present itself in the future.
    Jan 30, 2015. 05:07 PM | Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    You're right. CTIX did de-risk Brilacidin. That's why the price went from $.70 to $4.80 about a 7 bagger.

    A lot of positives are now baked into the price. Dilution is coming. I think a better entry point will be available in the future.
    Jan 30, 2015. 04:49 PM | 1 Like Like |Link to Comment
  • Nuvilex Inc: Why We Believe This Promoted Stock Is Worth Zero [View article]
    They send out tons of self promoting press releases. And absolutely ZERO peer reviewed articles. If they spent half the time doing R&D as they do in self promotion. This would be a whole different company!
    Jan 30, 2015. 04:02 PM | 1 Like Like |Link to Comment
  • Nuvilex Inc: Why We Believe This Promoted Stock Is Worth Zero [View article]
    Always believe your own due diligence. Nobody else's!
    Jan 30, 2015. 03:58 PM | Likes Like |Link to Comment
  • Nuvilex Inc: Why We Believe This Promoted Stock Is Worth Zero [View article]
    You Know, this dog has dropped so far -- so fast, I think we could be looking for a little dead cat bounce here.
    Jan 30, 2015. 02:35 PM | Likes Like |Link to Comment
  • Cellceutix Undervalued By 90+%; Expect A Short Squeeze Soon [View article]
    Back up the truck and BUY BUY BUY!

    A lot of over exuberance on this company. While there are possibilities for it, there are at least equal opportunities for failure. I sold my shares at $4.50 and I'll put it on my watchlist. I might get in later, if a better price presents itself.
    Jan 29, 2015. 06:55 PM | Likes Like |Link to Comment
  • PharmaCyte Biotech: A Re-Balanced, Statistical Look At Stock Promotions [View article]
    Bob . That assumes the company's goal is to make money. Of course it's equally possible that the company's goal is to provide a nice income for company execs for as long as possible. And they seem to be doing that very well. I don't think anyone's getting fired.
    Jan 27, 2015. 06:08 PM | 1 Like Like |Link to Comment
  • PharmaCyte Biotech (Formerly, Nuvilex): Where, Oh Where Did The Cash Flow Go... [View article]
    Instead of constantly sending out press release after press release telling us "HERE IS WHAT WE ARE GOING TO DO IN THE FUTURE!"

    It would be a real refreshing change if they waited a little and sent out a peer reviewed article about what they have actually accomplished.

    That would do a ton of good for their shady reputation.
    Jan 27, 2015. 05:47 PM | 2 Likes Like |Link to Comment
  • Cellceutix: A December To Remember May Turn Into A 2015 To Forget For CTIX [View article]
    Considering that almost all start up biotechs are a house of cards where one slip can be very painful, I never resent a short article. Does my long view hold up? I sold my ctix at $4.50. I will consider buying back in the future at a lower price.
    Jan 23, 2015. 05:08 PM | 1 Like Like |Link to Comment
  • Nuvilex Inc: Why We Believe This Promoted Stock Is Worth Zero [View article]
    You are right. I'll wish they'd spent their millions on clinical trials and R&D instead of "administrative costs" and stock promotions.
    Jan 23, 2015. 03:49 PM | Likes Like |Link to Comment
  • PharmaCyte Biotech (Formerly, Nuvilex): Where, Oh Where Did The Cash Flow Go... [View article]
    3 cents by July
    Jan 21, 2015. 03:07 PM | 1 Like Like |Link to Comment
COMMENTS STATS
72 Comments
26 Likes